Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Prof. Dr. med. Pauline Wimberger

Medizinische Fakultät, Klinik für Frauenheilkunde und Geburtshilfe

Funktionen

  • Privatdozent/in, Klinik für Frauenheilkunde und Geburtshilfe

Aktuelle Veranstaltungen

Keine aktuellen Veranstaltungen.

Vergangene Veranstaltungen (max. 10)

Keine vergangenen Veranstaltungen.

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Hamann, M.; Christgen, M.; Gluz, O.; Nitz, U.; Kuemmel, Sherko; Braun, M.; Thill, M.; Wuerstlein, R.; Wimberger, Pauline; Hartkopf, A.; Schem, C.; Zaiss, M.; Bjelic-Radisic, V.; Just, M.; Veselinovic, K.; Vincent, M.; Graeser, M.; Krauss, K.; Hoffmann, Oliver; Lüdtke-Heckenkamp, K.; Kates, R.E.; zu Eulenburg, C.; Jóźwiak, K.; Burmeister, S.; Hauptmann, M.; Baehner, F.; Schmid, P.; Kreipe, H.-H.; Harbeck, N.
    Endocrine response assessment in HR-positive HER2-negative early breast cancer : concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292)
    In: ESMO Open, Jg. 10, 2025, Nr. 8, 105552
    DOI (Open Access)
  • Denschlag, Dominik; Czogalla, Bastian; Heitz, Florian; Kerkmann, Markus; Fangmann, Laura-Christin; Klecker, Philip H.; Stuebs, Frederik A.; Wölber, Linn; Radosa, Julia; Lodde, Pia C.; Seitz, Stephan; George, Christian; Mach, Pawel; Fink, Angelina; Bokhua, Davit; Degregorio, Nikolaus; Lampe, Björn; Hemptenmacher, Franziska; Friebe, Verena; Fleisch, Markus; Wimberger, Pauline; Jaeger, Anna; Schnelzer, Andreas; Mittelstadt, Suzana; Ratiu, Dominik; Eichbaum, Michael; Haus, Adriana; Kalder, Matthias; Ataseven, Beyhan; Schröder, Willibald; Bronger, Holger; Kosse, Jens; Ulrich, Uwe Andreas; Elser, Gabriele; Harter, Philipp
    Evaluation of Baseline Characteristics and Therapeutic Management Strategies in Metastatic Cervical Cancer in Germany : A Multicentric Retrospective Longitudinal Observational Study
    In: Geburtshilfe und Frauenheilkunde, Jg. 85, 2025, Nr. 5, S. 520 – 532
    DOI (Open Access)
  • Chinczewski, Lukas; Harter, Philipp; Heukamp, Lukas; Mayr, Doris; Grimm, Christoph; Heinzelmann-Schwarz, Viola; Wimberger, Pauline; Mahner, Sven; Braicu, Ioana Elena; Schmitt, Wolfgang; Denkert, Carsten; Sehouli, Jalid
    Intergroup-statement : statement of the german ovarian cancer commission, the North-Eastern German Society of gynecological Oncology (NOGGO), AGO Austria and AGO Swiss regarding the use of homologous repair deficiency (HRD) assays in advanced ovarian cancer
    In: Archives of Gynecology and Obstetrics, Jg. 311, 2025, Nr. 5, S. 1445 – 1450
    DOI (Open Access)
  • Fehm, Tanja; Mueller, Volkmar; Banys-Paluchowski, Maggie; Fasching, Peter A.; Friedl, Thomas W P; Hartkopf, Andreas; Huober, Jens; Loehberg, Christian; Rack, Brigitte; Riethdorf, Sabine; Schneeweiss, Andreas; Wallwiener, Diethelm; Meier-Stiegen, Franziska; Krawczyk, Natalia; Jaeger, Bernadette; Reinhardt, Florian; Hoffmann, Oliver; Mueller, Lothar; Wimberger, Pauline; Ruckhaeberle, Eugen; Blohmer, Jens-Uwe; Cieslik, Jan-Philipp; Franken, André; Niederacher, Dieter; Neubauer, Hans; Pantel, Klaus; Janni, Wolfgang
    Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells-The DETECT III Clinical Trial
    In: Clinical Chemistry, Jg. 70, 2024, Nr. 1, S. 307 – 318
    DOI
  • Heublein, Sabine; Pfisterer, Jacobus; du Bois, Andreas; Anglesio, Michael; Aminossadati, Behnaz; Bhatti, Irfan; Sehouli, Jalid; Wimberger, Pauline; Schochter, Fabienne; Hilpert, Felix; Hillemanns, Peter; Kalder, Matthias; Schroeder, Willibald; Mahner, Sven; Burges, Alexander; Canzler, Ulrich; Gropp-Meier, Martina; Jackisch, Christian; Harter, Philipp; Kommoss, Stefan; Marmé, Frederik
    Fibroblast Growth Factor Receptors and Ligands in Context of Bevacizumab Response in Ovarian Carcinoma : An Exploratory Analysis of AGO-OVAR11/ICON-7
    In: Laboratory Investigation, Jg. 104, 2024, Nr. 4, 100321
    DOI
  • Zöllkau, Janine; Heimann, Yvonne; Hagenbeck, Carsten; Pecks, Ulrich; Abou-Dakn, Michael; Schlösser, Rolf; Schohe, Anna; Dressler-Steinbach, Iris; Manz, Maike; Banz-Jansen, Constanze; Reuschel, Edith; Iannaccone, Antonella; Bohlmann, Michael K.; Kraft, Katrina; Fill Malfertheiner, Sara; Wimberger, Pauline; Kolben, Thomas; Bartmann, Catharina; Carolin Longardt, Ann
    Breastfeeding Behavior Within the Covid-19 Related Obstetric and Neonatal Outcome Study (CRONOS)
    In: Journal of Human Lactation, Jg. 39, 2023, Nr. 4, S. 625 – 635
    DOI
  • Bossart, M.; Plett, H.; Krämer, B.; Braicu, E.; Czogalla, B.; Klar, M.; Singer, S.; Mayr, D.; Staebler, A.; du Bois, A.; Kommoss, S.; Link, T.; Burges, A.; Heitz, F.; Grube, M.; Trillsch, F.; Harter, P.; Wimberger, Pauline; Buderath, P.; Hasenburg, A.
    Depression and anxiety in women with malignant ovarian germ cell (MOGCT) and sex cord stromal tumors (SCST) : An analysis of the AGO-CORSETT database
    In: Archives of Gynecology and Obstetrics, Jg. 307, 2023, Nr. 4, S. 1155 – 1162
    DOI (Open Access)
  • Klotz, Daniel Martin; Schwarz, Franziska Maria; Dubrovska, Anna; Schuster, Kati; Theis, Mirko; Krüger, Alexander; Kutz, Oliver; Link, Theresa; Wimberger, Pauline; Drukewitz, Stephan; Buchholz, Frank; Thomale, Jürgen; Kuhlmann, Jan Dominik
    Establishment and Molecular Characterization of an In Vitro Model for PARPi-Resistant Ovarian Cancer
    In: Cancers, Jg. 15, 2023, Nr. 15, 3774
    DOI (Open Access)
  • Bossart, M.; Plett, H.; Krämer, B.; Braicu, E.; Czogalla, B.; Klar, M.; Singer, S.; Mayr, D.; Staebler, A.; du Bois, A.; Kommoss, S.; Link, T.; Burges, A.; Heitz, F.; Grube, M.; Trillsch, F.; Harter, P.; Wimberger, Pauline; Buderath, P.; Hasenburg, A.
    Psychische Belastung und deren Einflussfaktoren bei Überlebenden von malignen ovariellen Keimzell- oder Keimstrangstromatumoren : Eine Analyse der AGO-CORSETT-Datenbank
    In: Die Onkologie, Jg. 29, 2023, Nr. 5, S. 447 – 454
    DOI (Open Access)
  • Roser, Eva; Harter, Philipp; Zocholl, Dario; Denschlag, Dominik; Chekerov, Radoslav; Wimberger, Pauline; Kurzeder, Christian; Hasenburg, Annette; Muallem, Mustafa-Zelal; Mustea, Alexander; Emons, Guenter; Zeimet, A.G.; Beck, Felix; Arndt, Tjadina; Brucker, Sara Y; Kommoss, Stefan; Heitz, Florian; Welz, Julia; Egger, Eva-Katharina; Kalder, Matthias; Buderath, Paul; Klar, Maximilian; Marth, Christian; Ulrich, Uwe Andreas; Weigel, Michael; Traub, Lea; Anthuber, Christoph; Strauss, Hans; Hanker, Lars; Link, Theresa; Kubiak, Karol; Melekian, Badrig; Hornung, Daniela; Pölcher, Martin; Lampe, Bjoern; Krauß, Thomas; Keilholz, Ulrich; Flörcken, Anne; Pietzner, Klaus; Sehouli, Jalid
    Treatment strategies in patients with gynecological sarcoma : Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA-NOGGO RU1)
    In: International Journal of Gynecological Cancer, Jg. 33, 2023, Nr. 2, S. 223 – 230
    DOI
  • Wimberger, Pauline; Gerber, Mara Julia; Pfisterer, Jacobus; Erdmann, Kati; Füssel, Susanne; Link, Theresa; Du Bois, Andreas; Kommoss, Stefan; Heitz, Florian; Sehouli, Jalid; Kimmig, Rainer; De Gregorio, Nikolaus; Schmalfeldt, Barbara; Park-Simon, Tjoung-Won; Baumann, Klaus; Hilpert, Felix; Grube, Marcel; Schröder, Willibald; Burges, Alexander; Belau, Antje; Hanker, Lars; Kuhlmann, Jan Dominik
    Bevacizumab May Differentially Improve Prognosis of Advanced Ovarian Cancer Patients with Low Expression of VEGF-A₁₆₅b, an Antiangiogenic VEGF-A Splice Variant
    In: Clinical Cancer Research, Jg. 28, 2022, Nr. 21, S. 4660 – 4668
    DOI
  • Bachmann, Hagen Sjard; Jung, Dominik; Link, Theresa; Arnold, Anna; Kantelhardt, Eva; Thomssen, Christoph; Wimberger, Pauline; Vetter, Martina; Kuhlmann, Jan Dominik
    FNTB Promoter Polymorphisms Are Independent Predictors of Survival in Patients with Triple Negative Breast Cancer
    In: Cancers, Jg. 14, 2022, Nr. 3, 468
    DOI (Open Access)
  • Buderath, Paul; Stukan, Maciej; Ruhwedel, Wencke; Strutas, Deivis; Feisel-Schwickardi, Gabriele; Wimberger, Pauline; Kimmig, Rainer
    Total mesometrial resection (TMMR) for cervical cancer FIGO IB–IIA : First results from the multicentric TMMR register study
    In: Journal of Gynecologic Oncology, Jg. 33, 2022, Nr. 1, e9
    DOI, Online Volltext (Open Access)
  • Künzel, Stephan R.; Hoffmann, Maximilian; Weber, Silvio; Künzel, Karolina; Kämmerer, Susanne; Günscht, Mario; Klapproth, Erik; Rausch, Johanna S.E.; Sadek, Mirna S.; Kolanowski, Tomasz; Meyer-Roxlau, Stefanie; Piorkowski, Christopher; Tugtekin, Sems M.; Rose-John, Stefan; Yin, Xiaoke; Mayr, Manuel; Kuhlmann, Jan Dominik; Wimberger, Pauline; Grützmann, Konrad; Herzog, Natalie; Küpper, Jan-Heiner; O’Reilly, Molly; Kabir, S. Nashitha; Sommerfeld, Laura C.; Guan, Kaomei; Wielockx, Ben; Fabritz, Larissa; Nattel, Stanley; Ravens, Ursula; Dobrev, Dobromir; Wagner, Michael; El-Armouche, Ali; O'Reilly, Molly
    Diminished PLK2 Induces Cardiac Fibrosis and Promotes Atrial Fibrillation
    In: Circulation Research, Jg. 129, 2021, Nr. 8, S. 804 – 820
    DOI (Open Access)
  • Müller, V.; Banys-Paluchowski, M.; Friedl, T.W.P.; Fasching, P.A.; Schneeweiss, A.; Hartkopf, A.; Wallwiener, D.; Rack, B.; Meier-Stiegen, F.; Huober, J.; Rübner, M.; Hoffmann, Oliver; Müller, L.; Janni, W.; Wimberger, Pauline; Jäger, B.; Pantel, K.; Riethdorf, S.; Harbeck, N.; Fehm, T.
    Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program
    In: ESMO Open, Jg. 6, 2021, Nr. 6, 100299
    DOI (Open Access)
  • Hasenburg, Annette; Plett, Hellmut; Krämer, Bernhard; Braicu, Elena; Czogalla, Bastian; Bossart, Michaela; Singer, Susanne; Mayr, Doris; Staebler, Annette; du Bois, Andreas; Kommoss, Stefan; Link, Theresa; Burges, Alexander; Heitz, Florian; Keul, Jacqueline; Trillsch, Fabian; Harter, Philipp; Wimberger, Pauline; Buderath, Paul; Klar, Maximilian
    The effect of fertility-sparing surgery on sexuality and global quality of life in women with malignant ovarian germ cell and sex cord stromal tumors : An analysis of the CORSETT database of the AGO study group
    In: Archives of Gynecology and Obstetrics, Jg. 304, 2021, Nr. 6, S. 1541 – 1549
    DOI (Open Access)
  • Melnikova, Margarita; Wauer, Ulrike Sophie; Mendus, Diana; Hilger, Ralf Axel; Oliver, Trudy G.; Mercer, Kim; Gohlke, Björn Oliver; Erdmann, Kati; Niederacher, Dieter; Neubauer, Hans; Buderath, Paul; Wimberger, Pauline; Kuhlmann, Jan Dominik; Thomale, Jürgen
    Diphenhydramine increases the therapeutic window for platinum drugs by simultaneously sensitizing tumor cells and protecting normal cells
    In: Molecular Oncology, Jg. 14, 2020, Nr. 4, S. 686 – 703
    DOI (Open Access)
  • Canzler, Ulrich; Lück, Hans-Joachim; Neuser, Petra; Sehouli, Jalid; Burges, Alexander; Harter, Philipp; Schmalfeldt, Barbara; Aminossadati, Behnaz; Mahner, Sven; Kommoss, Stefan; Wimberger, Pauline; Pfisterer, Jacobus; de Gregorio, Nikolaus; Hasenburg, Annette; Gropp-Meier, Martina; El-Balat, Ahmed; Jackisch, Christian; du Bois, Andreas; Meier, Werner; Wagner, Uwe
    Prognostic role of thrombocytosis in recurrent ovarian cancer : a pooled analysis of the AGO Study Group
    In: Archives of Gynecology and Obstetrics, Jg. 301, 2020, Nr. 5, S. 1267 – 1274
    DOI
  • Wichmann, Catharina; Klotz, Daniel Martin; Zeiler, Hans-Joachim; Hilger, Ralf A.; Grützmann, Konrad; Krüger, Alexander; Aust, Daniela; Wimberger, Pauline; Kuhlmann, Jan Dominik
    The effect of the triazene compound CT913 on ovarian cancer cells in vitro and its synergistic interaction with the PARP-inhibitor olaparib
    In: Gynecologic Oncology, Jg. 159, 2020, Nr. 3, S. 850 – 859
    DOI
  • Kuhlmann, Jan Dominik; Bachmann, Hagen Sjard; Link, Theresa; Wimberger, Pauline; Kröber, Eric; Thomssen, Christoph; Mallé, Brahima; Bethmann, Daniel; Vetter, Martina; Kantelhardt, Eva Johanna
    Association of caspase 8 polymorphisms -652 6N InsDel and Asp302His with progression-free survival and tumor infiltrating lymphocytes in early breast cancer
    In: Scientific Reports, Jg. 9, 2019, Nr. 1, S. 12594
    DOI (Open Access)
  • Kuhlmann, Jan Dominik; Chebouti, Issam; Kimmig, Rainer; Buderath, Paul; Reuter, Michael; Puppel, Sven-Holger; Wimberger, Pauline; Kasimir-Bauer, Sabine
    Extracellular vesicle-associated miRNAs in ovarian cancer - design of an integrated NGS-based workflow for the identification of blood-based biomarkers for platinum-resistance
    In: Clinical Chemistry and Laboratory Medicine, Jg. 57, 2019, Nr. 7, S. 1053 – 1062
    DOI
  • Polterauer, Stephan; Schwameis, Richard; Grimm, Christoph; Hillemanns, Peter; Jückstock, Julia; Hilpert, Felix; Gregorio, Nikolaus de; Hasenburg, Annette; Sehouli, Jalid; Fürst, Sophie Theresa; Strauß, Hans Georg; Baumann, Klaus; Thiel, Falk; Mustea, Alexander; Harter, Philipp; Wimberger, Pauline; Kölbl, Heinz; Reinthaller, Alexander; Woelber, Linn; Mahner, Sven
    Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer : results from the AGO-CaRE-1 study
    In: Gynecologic Oncology, Jg. 153, 2019, Nr. 2, S. 286 – 291
    DOI
  • Rachner, Tilman D.; Kasimir-Bauer, Sabine; Gobel, Andy; Erdmann, Kati; Hoffmann, Oliver; Browne, Andrew; Wimberger, Pauline; Rauner, Martina; Hofbauer, Lorenz C.; Kimmig, Rainer; Bittner, Ann-Kathrin
    Prognostic value of RANKL/OPG serum levels and disseminated tumor cells in nonmetastatic breast cancer
    In: Clinical Cancer Research, Jg. 25, 2019, Nr. 4, S. 1369 – 1378
    DOI (Open Access)
  • Schmalfeldt, Barbara; Brambs, Christine; Burges, Alexander; El-Balat, Ahmed; Emons, Günter; Fink, Daniel; Fotopoulou, Christina; Gropp-Meier, Martina; Hanker, Lars-Christian; Harter, Philipp; Hasenburg, Annette; Hauptmann, Steffen; Hilpert, Felix; Kimmig, Rainer; Kommoss, Stefan; Kurzeder, Christian; Mahner, Sven; Marmé, Frederik; Mayr, Doris; Meier, Werner; Meinhold-Heerlein, Ivo; Mustea, Alexander; Ortmann, Olaf; Oskay-Özcelik, Gülten; Pfisterer, Jacobus; Pölcher, Martin; Runnebaum, Ingo B.; Schröder, Willibald; Tanner, Berno; Wagner, Uwe; Wimberger, Pauline; Sehouli, Jalid
    What is the evidence for lymphadenectomy in presumed early ovarian cancer?
    In: Archives of Gynecology and Obstetrics, Jg. 299, 2019, Nr. 1, S. 1 – 5
    DOI
  • Romashova, Tatiana; Polasik, Arkadius; Friedl, Thomas W. P.; Rack, Brigitte K.; Tzschaschel, Marie; Fasching, Peter Anton; Taran, Florin-Andrei; Hartkopf, Andreas Daniel; Schneeweiss, A.; Mueller, V; Bahriye, A; Pantel, Klaus; Meier-Stiegen, F; Wimberger, Pauline; Janni, Wolfgang; Fehm, Tanya; Huober, Jens Bodo
    Abstract OT1-03-05: The DETECT V-Study : Comparison of dual HER2-targeted therapy with trastuzumab plus pertuzumab in combination with chemo- or endocrine therapy in addition with CDK4/6 inhibition in patients with HER2-positive and hormone-receptor positive metastatic breast cancer
    In: Cancer Research, Jg. 78, 2018, Nr. 4, Supplement
    DOI
  • Romashova, T.; Polasik, A.; Tzschaschel, M.; Friedl, TWP; Kurt, A.; Rack, B.; Fasching, P. A.; Taran, F. A.; Hartkopf, A.; Schneeweiss, A.; Muller, V.; Aktas, B.; Pantel, K.; Meier-Stiegen, F.; Wimberger, Pauline; Janni, W.; Fehm, T.
    DETECT III und IV - Individualized CTC-based therapy of metastatic breast cancer
    In: Oncology Research and Treatment, Jg. 41, 2018, Nr. Suppl. 1, S. 32
  • Dittrich, Ralf; Kliesch, Sabine; Schüring, Andreas; Balcerek, Magdalena; Baston-Büst, Dunja M.; Beck, Ramona; Beckmann, Matthias W.; Behringer, Karolin; Borgmann-Staudt, Anja; Cremer, Wolfgang; Denzer, Christian; Diemer, Thorsten; Dorn, Almut; Fehm, Tanja; Gaase, Rüdiger; Germeyer, Ariane; Geue, Kristina; Ghadjar, Pirus; Goeckenjan, Maren; Götte, Martin; Guth, Dagmar; Hauffa, Berthold; Hehr, Ute; Hetzer, Franc; Hirchenhain, Jens; Hoffmann, Wilfried; Hornemann, Beate; Jantke, Andreas; Kentenich, Heribert; Kiesel, Ludwig; Köhn, Frank-Michael; Korell, Matthias; Lax, Sigurd; Liebenthron, Jana; Lux, Michael; Meißner, Julia; Micke, Oliver; Nassar, Najib; Nawroth, Frank; Nordhoff, Verena; Ochsendorf, Falk; Oppelt, Patricia G.; Pelz, Jörg; Rau, Beate; Reisch, Nicole; Riesenbeck, Dorothea; Schlatt, Stefan; Sender, Annekathrin; Schwab, Roxana; Siedentopf, Friederike; Thorn, Petra; Wagner, Steffen; Wildt, Ludwig; Wimberger, Pauline; Wischmann, Tewes; Von Wolff, Michael; Lotz, Laura
    Fertility Preservation for Patients with Malignant Disease. : Guideline of the DGGG, DGU and DGRM (S2k-Level, AWMF Registry No. 015/082, November 2017) - Recommendations and Statements for Girls and Women
    In: Geburtshilfe und Frauenheilkunde, Jg. 78, 2018, Nr. 6, S. 567 – 584
    DOI (Open Access)
  • Koch, Yvonne; Wimberger, Pauline; Grümmer, Ruth
    Human chorionic gonadotropin induces decidualization of ectopic human endometrium more effectively than forskolin in an in-vivo endometriosis model
    In: Experimental Biology and Medicine, Jg. 243, 2018, Nr. 11, S. 953 – 962
    DOI, Online Volltext (Open Access)
  • Romashova, T.; Polasik, A.; Friedl, TWP; Rack, B.; Tzschaschel, M.; Fasching, P. A.; Taran, F. A.; Hartkopf, A.; Schneeweiss, A.; Muller, V.; Aktas, B.; Pantel, K.; Meier-Stiegen, F.; Wimberger, Pauline; Janni, W.; Fehm, T.; Huober, J.
    The DETECT V-Study - Comparison of dual HER2-targeted therapy with Trastuzumab plus Pertuzumab in combination with Chemo- or Endocrine Therapy in Addition with CDK4/6 Inhibition in Patients with HER2-positive and Hormone-receptor positive Metastatic Breas
    In: Oncology Research and Treatment, Jg. 41, 2018, Nr. Suppl. 1, S. 33 – 33
  • Fasching, P. A.; Grischke, E. M.; Schuetz, F.; Decker, T.; Uleer, C.; Salat, C.; Foerster, F.; Schmidt, M.; Mundhenke, C.; Tesch, H.; Jackisch, C.; Wimberger, Pauline; Aktas, B.; Zahn, M. O.; Tome, O.; Bloch, W.; Hanson, S.; Fischer, T.; Schubert, J.; Lueftner, D.
    Analysis of everolimus starting dose as prognostic marker in HR plus mBC patients treated with everolimus (EVE) plus exemestane (EXE) : Results of the 3rd interim analysis of the non-interventional trial BRAWO
    In: Journal of Clinical Oncology (JCO), Jg. 35, 2017, Nr. Suppl. 15, S. 1061
    DOI
  • Janni, W; Meier-Stiegen, F; Fehm, T; Taran, F-A; Schramm, Alexander; Schneeweiss, A; Hartkopf, A; Trapp, E; Polasik, A; Friedl, TWP; Müller, V; Fasching, PA; Rack, B; Pantel, K; Wimberger, Pauline; Aktas, B
    DETECT III and IV – Individualized CTC-based therapy of metastatic breast cancer
    In: Cancer Research, Jg. 77, 2017, Nr. 4, S. OT3 – 04
    DOI
  • Chebouti, Issam; Kasimir-Bauer, Sabine; Buderath, Paul; Wimberger, Pauline; Hauch, Siegfried; Kimmig, Rainer; Kuhlmann, Jan Dominik
    EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapy
    In: OncoTarget, Jg. 8, 2017, Nr. 30, S. 48820 – 48831
    DOI (Open Access)
  • Chebouti, Issam; Kuhlmann, Jan Dominik; Buderath, Paul; Weber, Stephan; Wimberger, Pauline; Bokeloh, Yvonne; Hauch, Siegfried; Kimmig, Rainer; Kasimir-Bauer, Sabine
    ERCC1-expressing circulating tumor cells as a potential diagnostic tool for monitoring response to platinum-based chemotherapy and for predicting post-therapeutic outcome of ovarian cancer
    In: OncoTarget, Jg. 8, 2017, Nr. 15, S. 24303 – 24313
    DOI (Open Access)
  • Jackisch, C.; Fasching, P. A.; Grischke, E. M.; Schuetz, F.; Decker, T.; Uleer, C.; Salat, C.; Foerster, F.; Schmidt, M.; Mundhenke, C.; Tesch, H.; Wimberger, Pauline; Aktas, B.; Zahn, M. O.; Tome, O.; Bloch, W.; Hanson, S.; Schubert, J.; Lueftner, D.
    Median progression free survival (PFS) for patients treated with everolimus (EVE) plus exemestane (EXE) for HR plus mBC in routine clinical practice : Results of the 3rd interim analysis of the non-interventional trial BRAWO
    In: Journal of Clinical Oncology (JCO), Jg. 35, 2017, Nr. Suppl. 15, S. e12547
    DOI
  • Klapdor, Rüdiger; Hillemanns, Peter; Wölber, Linn; Jückstock, Julia; Hilpert, Felix; de Gregorio, Nikolaus; Iborra, Severine; Sehouli, Jalid; Habermann, Anika; Fürst, Sophie Teresa; Strauß, Hans Georg; Baumann, Klaus; Thiel, Falk; Mustea, Alexander; Meier, Werner; Harter, Philipp; Wimberger, Pauline; Hanker, Lars; Schmalfeldt, Barbara; Canzler, Ulrich; Fehm, Tanja; Luyten, Alexander; Hellriegel, Martin; Kosse, Jens; Heiss, Christoph; Hantschmann, Peer; Mallmann, Peter; Tanner, Berno; Pfisterer, Jacobus; Richter, Barbara; Jäger, Martin; Mahner, Sven
    Outcome After Sentinel Lymph Node Dissection in Vulvar Cancer : A Subgroup Analysis of the AGO-CaRE-1 Study
    In: Annals of Surgical Oncology, Jg. 24, 2017, Nr. 5, S. 1314 – 1321
    DOI
  • Kurt, S; Wimberger, Pauline; Rainer, K; Jan Dominik, K; Winfried, S; Rainer, C; Agnes, B; Hagen, B
    Prognostic relevance of caspase 8 polymorphisms for breast cancer
    In: Cancer Research, Jg. 77, 2017, Nr. 4, S. P4 – 12
    DOI
  • Bittner, A-K; Kimmig, Rainer; Hoffmann, Oliver; Wimberger, Pauline; Rauner, M; Kasimir-Bauer, Sabine; Browne, AJ; Rachner, TD; Hofbauer, LC; Goebel, A
    Serum levels of RANKL are increased in primary breast cancer patients in the presence of disseminated tumor cells in the bone marrow
    In: Cancer Research, Jg. 77, 2017, Nr. 4
    DOI
  • Friedl, TWP; Schramm, A; Aktas, B; Müller, V; Rack, B; Fehm, T; Pantel, K; Hartkopf, A; Wimberger, Pauline; Tzschaschel, M; Trapp, E; Schneeweiss, A; Meier-Stiegen, F; Taran, F-A; Janni, W; Fasching, PA; Polasik, A
    The DETECT V-study – Comparison of dual HER2-targeted therapy with trastuzumab plus pertuzumab in combination with chemo- or endocrine therapy in patients with HER2-positive and hormone-receptor positive metastatic breast cancer
    In: Cancer Research, Jg. 77, 2017, Nr. 4, S. OT1 – 02
    DOI
  • Chebouti, Issam; Blassl, Christina; Wimberger, Pauline; Neubauer, Hans; Fehm, Tanja; Kimmig, Rainer; Kasimir-Bauer, Sabine
    Analysis of disseminated tumor cells before and after platinum based chemotherapy in primary ovarian cancer : Do stem cell like cells predict prognosis?
    In: OncoTarget, Jg. 7, 2016, Nr. 18, S. 26454 – 26464
    DOI (Open Access)
  • Wimberger, Pauline; Bankfalvi, Agnes; Schmid, Kurt Werner; Callies, Rainer; Kimmig, Rainer; Kuhlmann, J. D.; Siffert, Winfried; Bachmann, Hagen Sjard
    Caspase-8 Polymorphisms As Independent Prongostic Factors For Survival In Breast Cancer Patients
    In: International Journal of Gynecological Cancer, Jg. 26, 2016, Nr. Suppl. 2, S. 30
    DOI
  • Chebouti, I.; Blassl, C.; Wimberger, Pauline; Neubauer, H.; Fehm, T.; Kimmig, Rainer; Kasimir-Bauer, Sabine
    Do disseminated tumor cells with stem cell character after therapy predict prognosis in primary ovarian cancer
    In: Cancer Research, Jg. 76, 2016, Nr. 14 Suppl., S. 2492
    DOI
  • Muallem, Mustafa Zelal; Dimitrova, Desislava; Pietzner, Klaus; Richter, Rolf; Feldheiser, Aarne; Scharfe, Irina; Schmeil, Iryna; Hösl, Teresa Maria; Mustea, Alexander; Wimberger, Pauline; Burges, Alexander; Kimmig, Rainer; Sehouli, Jalid
    Implementation of Enhanced Recovery After Surgery (ERAS) Pathways in Gynecologic Oncology : A NOGGO-AGO* survey of 144 Gynecological Departments in Germany
    In: Anticancer Research, Jg. 36, 2016, Nr. 8, S. 4227 – 4232
  • Kuhlmann, J D; Bankfalvi, Agnes; Schmid, Kurt Werner; Callies, Rainer; Kimmig, Rainer; Wimberger, Pauline; Siffert, Winfried; Bachmann, Hagen Sjard
    Prognostic relevance of caspase 8 -652 6N InsDel and Asp302His polymorphisms for breast cancer
    In: BMC Cancer, Jg. 16, 2016, S. 618
    DOI (Open Access)
  • Kuhlmann, J. D.; Bankfalvi, Agnes; Kimmig, Rainer; Schmidt, K. W.; Bachmann, Hagen Sjard; Wimberger, Pauline
    Prognostische Relevanz von Caspase-8 Polymorphismen für das Mammakarzinom
    In: Geburtshilfe und Frauenheilkunde, Jg. 76, 2016, Nr. 5, A 30
    DOI
  • Wimberger, Pauline; Kuhlmann, J.; Bankfalvi, Agnes; Keller, T.; Scholer, S.; Aktas, B.; Buderath, P.; Hauch, S.; Otterbach, F.; Kimmig, Rainer; Kasimir-Bauer, Sabine
    ERCC1-positive circulating tumor cells in the blood of ovarian cancer patients as a predictive biomarker for platinum-restistance
    In: International Journal of Gynecological Cancer, Jg. 25, 2015, Nr. 9 (Supplement 1), S. 464
    DOI
  • Farthmann, Juliane; Hasenburg, Annette; Weil, Meike; Fotopoulou, Christina; Ewald-Riegler, Nina; Du Bois, Oya; Trillsch, Fabian; Mahner, Sven; Strauss, Hans-Georg; Wimberger, Pauline; Reuss, Alexander; Du Bois, Andreas
    Quality of life and sexual function in patients with borderline tumors of the ovary : A substudy of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) study group ROBOT study
    In: Supportive Care in Cancer, Jg. 23, 2015, Nr. 1, S. 117 – 123
    DOI
  • Heubner, Martin; Wimberger, Pauline; Kasimir-Bauer, Sabine; Singer, Bernhard B.; Ruf, Peter; Kimmig, Rainer; Siffert, Winfried
    Single nucleotide polymorphisms of the EpCAM-coding gene TACSTD1 in patients with ovarian cancer and their potential translational aspects
    In: Archives of Gynecology and Obstetrics, Jg. 292, 2015, Nr. 6, S. 1367 – 1372
    DOI
  • Trillsch, Fabian; Mahner, Sven; Vettorazzi, Eik; Woelber, Linn; Reuß, Alexander; Baumann, Klaus; Keyver-Paik, Mignon-Denise; Canzler, Ulrich; Wollschlaeger, Kerstin; Forner, Dirk; Pfisterer, Jacobus; Schroeder, Willibald; Muenstedt, Karsten; Richter, Barbara; Fotopoulou, Christina; Schmalfeldt, Barbara; Burges, Alexander; Ewald-Riegler, Nina; Gregorio, Nikolaus de; Hilpert, Felix; Fehm, Tanja; Meier, Werner; Hillemanns, Peter; Hanker, Lars; Hasenburg, Annette; Strauß, Hans-Georg; Hellriegel, Martin; Wimberger, Pauline; Kommoss, Stefan; Kommoss, Friedrich; Hauptmann, Steffen; Du Bois, Andreas
    Surgical staging and prognosis in serous borderline ovarian tumours (BOT) : a subanalysis of the AGO ROBOT study
    In: British Journal of Cancer (BJC), Jg. 112, 2015, Nr. 4, S. 660 – 666
    DOI (Open Access)
  • Bachmann, Hagen Sjard; Wimberger, Pauline; Aminossadati, Behnaz; Schmalfeldt, Barbara; Burges, Alexander; Hillemanns, Peter; Huober, Jens B.; Wollschlaeger, Kerstin M.; Sehouli, Jalid; Siffert, Winfried; Kuhlmann, Jan Dominik; Kimmig, Rainer; Du Bois, Andreas; Meier, Werner
    The FNTB promoter polymorphism rs11623866 as a potential predictive biomarker for lonafarnib treatment of ovarian cancer patients
    In: British Journal of Clinical Pharmacology (BJCP), Jg. 80, 2015, Nr. 5, S. 1139 – 1148
    DOI (Open Access)
  • Fotopoulou, Christina; Sehouli, Jalid; Ewald-Riegler, Nina; De Gregorio, Nikolaus; Reuss, Alexander; Richter, Rolf; Mahner, Sven; Kommoss, Friedrich; Schmalfeldt, Barbara; Fehm, Tanja; Hanker, Lars; Wimberger, Pauline; Canzler, Ulrich; Pfisterer, Jacobus; Kommoss, Stefan; Du Bois, Andreas; Wagner, U.; Kuhn, W.; Peters, M.; Harter, Philipp; Kurzeder, Christian; Trillsch, Fabian; Avril, Stefanie; Kühnle, E.; Rothmund, Ralf; Mayr, Doris; Tjahadi, M.; Markert, S.; Keyver-Paik, Mignon Denise Enise; Thomssen, Christoph; Richter, C.; Emons, Günter; Kimmig, Rainer; Nasemann, C.; Schröder, Willibald; Münstedt, Karsten; Richter, Barbara Diane; Meier, Werner; Hillemanns, Peter; Forner, Dirk Michael; Wollschlaeger, Kerstin M.; Hasenburg, Annette; Burges, Alexander; Strauß, Hans Georg; Hellriegel, Martin; Baumann, Klaus Heinrich; Hilpert, Felix
    The value of serum CA125 in the diagnosis of borderline tumors of the ovary : A subanalysis of the prospective multicenter ROBOT study
    In: International Journal of Gynecological Cancer, Jg. 25, 2015, Nr. 7, S. 1248 – 1252
    DOI (Open Access)
  • Söhngen, Linda; Schmidt, Markus; Wimberger, Pauline; Kimmig, Rainer; Grümmer, Ruth
    Additional B-cell deficiency does not affect growth and angiogenesis of ectopic human endometrium in T-cell-deficient endometriosis mouse models during long-term culture
    In: Journal of Reproductive Immunology, Jg. 106, 2014, Nr. 1, S. 50 – 57
    DOI
  • Trillsch, F.; Mahner, S.; Woelber, L.; Vettorazzi, E.; Reuss, A.; Ewald-Riegler, N.; Gregorio, N. de; Fotopoulou, C.; Schmalfeldt, B.; Burges, A.; Hilpert, F.; Fehm, T.; Meier, W.; Hillemanns, P.; Hanker, L.; Hasenburg, A.; Strauss, H. G.; Hellriegel, M.; Wimberger, Pauline; Baumann, K.; Keyver-Paik, M. D.; Canzler, U.; Wollschlaeger, K.; Forner, D.; Pfisterer, J.; Schroeder, W.; Muenstedt, K.; Richter, B.; Kommoss, F.; Hauptmann, S.; du Bois, A.
    Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome : Results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study
    In: Annals of Oncology, Jg. 25, 2014, Nr. 7, S. 1320 – 1327
    DOI
  • Pujade-Lauraine, Eric; Hilpert, Felix; Weber, Béatrice; Reuss, Alexander; Poveda, Andres; Kristensen, Gunnar; Sorio, Roberto; Vergote, Ignace; Witteveen, Petronella; Bamias, Aristotelis; Pereira, Deolinda; Wimberger, Pauline; Oaknin, Ana; Mirza, Mansoor Raza; Follana, Philippe; Bollag, David; Ray-Coquard, Isabelle
    Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer : The AURELIA Open-Label Randomized Phase III Trial
    In: Journal of Clinical Oncology (JCO), Jg. 32, 2014, Nr. 13, S. 1302 – 1308
    DOI
  • Kuhlmann, Jan Dominik; Baraniskin, Alexander; Hahn, Stephan A.; Mosel, Frank; Bredemeier, Maren; Wimberger, Pauline; Kimmig, Rainer; Kasimir-Bauer, Sabine
    Circulating U2 Small Nuclear RNA Fragments as a Novel Diagnostic Tool for Patients with Epithelial Ovarian Cancer
    In: Clinical Chemistry, Jg. 60, 2014, Nr. 1, S. 206 – 213
    DOI
  • Kuhlmann, Jan Dominik; Wimberger, Pauline; Bankfalvi, Agnes; Keller, Thomas; Schöler, Sarah; Aktas, Bahriye; Buderath, Paul; Hauch, Siegfried; Otterbach, Friedrich; Kimmig, Rainer; Kasimir-Bauer, Sabine
    ERCC1-Positive Circulating Tumor Cells in the Blood of Ovarian Cancer Patients as a Predictive Biomarker for Platinum Resistance
    In: Clinical Chemistry, Jg. 60, 2014, Nr. 10, S. 1282 – 1289
    DOI
  • Emons, Günter; Gorchev, Grigor; Sehouli, Jalid; Wimberger, Pauline; Stähle, Anne; Hanker, Lars; Hilpert, Felixci; Sindermann, Herbert; Gründker, Carsten; Harter, Philipp
    Efficacy and safety of AEZS-108 (INN: Zoptarelin Doxorubicin Acetate) an LHRH agonist linked to doxorubicin in women with platinum refractory or resistant ovarian cancer expressing LHRH receptors : A multicenter Phase II trial of the ago-study group (AGO GYN 5)
    In: Gynecologic Oncology, Jg. 133, 2014, Nr. 3, S. 427 – 432
    DOI
  • Emons, Günter; Gorchev, Grigor; Harter, Philip; Wimberger, Pauline; Stähle, Anne; Hanker, Lars; Hilpert, Felix; Beckmann, Matthias W.; Dall, Peter; Gründker, Carsten; Sindermann, Herbert; Sehouli, Jalid
    Efficacy and safety of AEZS-108 (LHRH agonist linked to doxorubicin) in women with advanced or recurrent endometrial cancer expressing LHRH receptors : A multicenter phase 2 trial (AGO-GYN5)
    In: International Journal of Gynecological Cancer, Jg. 24, 2014, Nr. 2, S. 260 – 265
    DOI (Open Access)
  • Wimberger, Pauline; Chebouti, Issam; Kasimir-Bauer, Sabine; Lachmann, Robert; Kuhlisch, Eberhard; Kimmig, Rainer; Süleyman, Ergün; Kuhlmann, Jan D.
    Explorative investigation of vascular endothelial growth factor receptor expression in primary ovarian cancer and its clinical relevance
    In: Gynecologic Oncology, Jg. 133, 2014, Nr. 3, S. 467 – 472
    DOI
  • Heubner, MartinLeon; Wimberger, Pauline; Kasimir-Bauer, Sabine; Singer, Bernhard B.; Ruf, Peter; Kimmig, Rainer; Siffert, Winfried
    Single nucleotide polymorphism of the EpCAM-coding gene TACSTD1 in patients with ovarian cancer and their potential implications in clinical practice
    In: Journal of Clinical Oncology (JCO), Jg. 32, 2014, Nr. 15 Suppl., S. e16515
    DOI
  • Heitz, Florian; Amant, Frederic; Fotopoulou, Christina; Battista, Marco J.; Wimberger, Pauline; Traut, Alexander; Fisseler-Eckhoff, A.; Harter, Philipp; Vandenput, Ingrid; Sehouli, Jalid; Schmidt, Markus; Kimmig, Rainer; Du Bois, Rabea; Du Bois, Andreas
    Synchronous ovarian and endometrial cancer-an international multicenter case-control study
    In: International Journal of Gynecological Cancer, Jg. 24, 2014, Nr. 1, S. 54 – 60
    DOI
  • Wimberger, Pauline; Bachmann, Hagen Sjard; Du Bois, A.; Kimmig, Rainer; Kuhlmann, J. D.; Siffert, Winfried; Sehoull, J.; Wollschlaeger, K.; Huober, J. B.; Hillemanns, P.; Burges, A.; Schmalfeldt, B.; Amlnossadatl, B.; Meier, W.
    The FNTB-609G>C polymorphism as a possible predictive factor for efficacy of lonafarnib-treatment? : Exploratory analysis of a randomized phase II clinical trial in stage IIb-IV ovarian cancer, treated with first-line platinum-based chemotherapy with or without lonafarnib
    In: Journal of Clinical Oncology (JCO), Jg. 32, 2014, Nr. 15 Suppl., S. e16534
    DOI
  • Cognetti, F.; Bagnato, A.; Colombo, N.; Savarese, A.; Scambia, G.; Sehouli, J.; Wimberger, P.; Sorio, R.; Harter, P.; Mari, E.; McIntosh, S.; Nathan, F.; Pemberton, K.; Baumann, K.
    A phase II, randomized, double-blind study of zibotentan (ZD4054) in combination with carboplatin/paclitaxel versus placebo in combination with carboplatin/paclitaxel in patients with advanced ovarian cancer sensitive to platinum-based chemotherapy (AGO-OVAR 2.14)
    In: Gynecologic Oncology, Jg. 130, 2013, Nr. 1, S. 31 – 37
    DOI
  • Sabbatini, Paul; Harter, Philipp; Scambia, Giovanni; Sehouli, Jalid; Meier, Werner; Wimberger, Pauline; Baumann, Klaus H.; Kurzeder, Christian; Schmalfeldt, Barbara; Cibula, David; Bidzinski, Mariusz; Casado, Antonio; Martoni, Andrea; Colombo, Nicoletta; Holloway, Robert W.; Selvaggi, Luigi; Li, Andrew; Campo, Jose Del; Karel Cwiertka; Tamas Pinter; Jan B. Vermorken; Eric Pujade-Lauraine; Simona Scartoni; Monica Bertolotti; Cecilia Simonelli; Angela Capriati; Carlo Alberto Maggi; Jonathan S. Berek; Jacobus Pfisterer
    Abagovomab as maintenance therapy in patients with epithelial ovarian cancer : a phase III trial of the AGO OVAR, COGI, GINECO, and GEICO-the MIMOSA study
    In: Journal of Clinical Oncology (JCO), Jg. 31, 2013, Nr. 12, S. 1554 – 1561
    DOI
  • Du Bois, Andreas; Ewald-Riegler, Nina; De Gregorio, Nikolaus; Reuss, Alexander; Mahner, Sven; Fotopoulou, Christina; Kommoss, Friedrich; Schmalfeldt, Barbara; Hilpert, Felix; Fehm, Tanja; Burges, Alexander; Meier, Werner; Hillemanns, Peter; Hanker, Lars; Hasenburg, Annette; Strauss, Hans-Georg; Hellriegel, Martin; Wimberger, Pauline; Keyver-Paik, Mignon-Denise; Baumann, Klaus; Canzler, Ulrich; Wollschlaeger, Kerstin; Forner, Dirk; Pfisterer, Jacobus; Schröder, Willibald; Münstedt, Karsten; Richter, Barbara; Kommoss, Stefan; Hauptmann, Steffen
    Borderline tumours of the ovary : a cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group
    In: European Journal of Cancer (EJC), Jg. 49, 2013, Nr. 8, S. 1905 – 1914
    DOI
  • Wimberger, Pauline; Chebouti, I.; Kuhlmann, J. D.; Kimmig, Rainer; Kuhlisch, E.; Lachmann, R.; Kasimir-Bauer, Sabine
    Clinical relevance of VEGF-receptor status in primary ovarian cancer : A pilot study for future biomarker analyses
    In: Journal of Clinical Oncology (JCO), Jg. 31, 2013, Nr. 15, Suppl., S. 5556
  • Kimmig, Rainer; Iannaccone, Antonella; Buderath, Paul; Aktas, Bahriye; Wimberger, Pauline; Heubner, Martin
    Definition of compartment based radical surgery in uterine cancer-part I : therapeutic pelvic and periaortic lymphadenectomy by Michael höckel translated to robotic surgery
    In: ISRN Obstetrics and Gynecology, 2013, S. 297921
    DOI
  • Kimmig, Rainer; Aktas, Bahriye; Buderath, Paul; Wimberger, Pauline; Iannaccone, Antonella; Heubner, Martin
    Definition of compartment-based radical surgery in uterine cancer : Modified radical hysterectomy in intermediate/high-risk endometrial cancer using peritoneal mesometrial resection (PMMR) by M Höckel translated to robotic surgery
    In: World Journal of Surgical Oncology, Jg. 11, 2013, S. 198
    DOI (Open Access)
  • Kimmig, Rainer; Wimberger, Pauline; Buderath, Paul; Aktas, Bahriye; Iannaccone, Antonella; Heubner, Martin
    Definition of compartment-based radical surgery in uterine cancer : radical hysterectomy in cervical cancer as 'total mesometrial resection (TMMR)' by M Höckel translated to robotic surgery (rTMMR)
    In: World Journal of Surgical Oncology, Jg. 11, 2013, S. 211
    DOI (Open Access)
  • Rupprich, K.; Wimberger, Pauline; Wieland, Regina; Eggert, Angelika; Grabellus, Florian; Schneider (T.), Tim; Wulff, Beate
    Paraneoplastic hypercalcemia associated with juvenile granulosa cell tumor
    In: Klinische Pädiatrie, Jg. 225, 2013, Nr. 3, S. 170 – 171
    DOI
  • Fehm, T.; Banys, M.; Rack, B.; Janni, W.; Marth, C.; Blassl, C.; Hartkopf, A.; Trope, C.; Kimmig, Rainer; Krawczyk, N.; Wallwiener, D.; Wimberger, Pauline; Kasimir-Bauer, Sabine
    Pooled analysis of the prognostic relevance of disseminated tumor cells in the bone marrow of patients with ovarian cancer
    In: International Journal of Gynecological Cancer, Jg. 23, 2013, Nr. 5, S. 839 – 845
    DOI
  • Farthmann, J.; Hasenburg, A.; Fotopoulou, C.; Ewald-Riegler, N.; Trillsch, F.; Mahner, S.; Strauss, H. G.; Wimberger, Pauline; Reuss, A.; du Bois, A.
    Quality of life and sexual function in patients with borderline tumors of the ovary : A substudy of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) study group ROBOT study
    In: International Journal of Gynecological Cancer, Jg. 23, 2013, Nr. Suppl. 8
  • Roder, H.; Kasimir-Bauer, Sabine; Kimmig, Rainer; Wimberger, Pauline; Zeillinger, R.; Castillo-Tong, D. C.; Sehouli, J.; Vergote, I.; Mahner, S.; Roder, J.; Grigorieva, J.; Meyer, K.; Aktas, B.
    Serum mass spectrometry analysis in primary ovarian cancer (OC) treated with surgery and adjuvant chemotherapy (CT)
    In: Journal of Clinical Oncology (JCO), Jg. 31, 2013, Nr. Suppl. 15
  • Kuhlmann, J. D.; Wimberger, Pauline; Aktas, B.; Kimmig, Rainer; Kasimir-Bauer, Sabine
    The persistence of ERCC1-positive circulating tumor cells predicts worse prognosis in patients with primary ovarian cancer
    In: Cancer Research, Jg. 73, 2013, Nr. Suppl. 8
    DOI
  • Aktas, Bahriye; Kasimir-Bauer, Sabine; Wimberger, Pauline; Kimmig, Rainer; Heubner, Martin
    Utility of mesothelin, L1CAM and afamin as biomarkers in primary ovarian cancer
    In: Anticancer Research, Jg. 33, 2013, Nr. 1, S. 329 – 336
    Online Volltext
  • Baumann, Klaus H.; Du Bois, Andreas; Meier, Werner; Rau, J.; Wimberger, Pauline; Sehouli, Jalid; Kurzeder, Christian; Hilpert, Felix; Hasenburg, Annette; Canzler, Ulrich; Hanker, Lars C.; Hillemanns, Peter; Richter, Barbara; Wollschlaeger, Kerstin; Dewitz, Thomas; Bauerschlag, Dirk; Wagner, Uwe
    A phase II trial (ago 2.11) in platinum-resistant ovarian cancer : a randomized multicenter trial with sunitinib (su11248) to evaluate dosage, schedule, tolerability, toxicity and effectiveness of a multitargeted receptor tyrosine kinase inhibitor monotherapy
    In: Annals of Oncology, Jg. 23, 2012, Nr. 9, S. 2265 – 2271
    DOI (Open Access)
  • Sehouli, J.; Wimberger, Pauline; Vergote, I. B.; Rosenberg, P.; Schneeweiss, A.; Bokemeyer, C.; Salat, C.; Scambia, G.; Berton-Rigaud, D.; Lordick, F.
    Catumaxomab versus Catumaxomab plus prednisolone in patients with malignant ascites due to epithelial cancer : results from the casimas study
    In: Annals of Oncology, Jg. 23, 2012, Nr. Suppl. 9, S. 539
  • Lordick, F.; Wimberger, Pauline; Vergote, I.; Rosenberg, P.; Schneeweiss, A.; Bokemeyer, C.; Salat, C.; Scambia, G.; Berton-Rigaud, D.; Siena, S.; Santoro, A.; Cervantes-Ruiperez, A.; Guastalla, J. P.; Tournigand, C.; Colombo, N.; Dudnitchenko, A. S.; Bondar, V.; Westermann, A. M.; Sehouli, J.
    Catumaxomab versus catumaxomab plus prednisolone in patients with malignant ascites due to epithelial cancer : results from the CASIMAS study
    In: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 63 – 63
  • Grümmer, Ruth; Wimberger, Pauline; Kimmig, Rainer; Koch, Y.
    Decidualization in human ectopic endometrial lesions in vivo is induced by hCG
    In: Human Reproduction, Jg. 27, 2012, Nr. Suppl. 2, S. O – 203
  • Wimberger, Pauline; Banys, M.; Kasimir-Bauer, Sabine; Hartkopf, A. D.; Krawczyk, N.; Marth, C.; Kimmig, Rainer; Neubauer, H.; Wallwiener, D.; Fehm, T. N.
    Detection of disseminated tumor cells in bone marrow as an independent prognostic factor in primary ovarian cancer patients
    In: Journal of Clinical Oncology (JCO), Jg. 30, 2012, Nr. 15, Suppl.
  • Wimberger, Pauline; Gilet, Hélène; Gonschior, A-K.; Heiss, Markus Maria; Moehler, Markus H.; Oskay-Oezcelik, Guelten; Al-Batran, Salah Eddin; Schmalfeldt, Barbara; Schmittel, Alexander; Schulze, Elisabeth; Parsons, Simon L.
    Deterioration in quality of life (QOL) in patients with malignant ascites : Results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone
    In: Annals of Oncology, Jg. 23, 2012, Nr. 8, S. 1979 – 1985
    DOI (Open Access)
  • Schmalfeldt, B.; Burges, A.; Hilpert, F.; Reuss, A.; Fehm, T.; Meier, W.; Kommoss, F.; Hillemanns, P.; Hanker, L.; Hasenburg, A.; Strauss, H. G.; Hellriegel, M.; Wimberger, Pauline; Kommoss, S.; Ewald-Riegler, N.; de Gregorio, N.; Mahner, S.; Fotopoulou, C.; Hauptmann, S.; du Bois, A.
    Disease Progression in female Patients with borderline ovarian Tumors : Results of the multicentric AGO 'ROBOT' Study
    In: Geburtshilfe und Frauenheilkunde, Jg. 72, 2012, Nr. 7, S. P15
  • Jäger, Michael; Schoberth, Alexandra; Ruf, Peter; Hess, Juergen; Hennig, Michael; Schmalfeldt, Barbara; Wimberger, Pauline; Stroḧlein, Michael; Theissen, Bettina; Heiss, Markus M.; Lindhofer, Horst
    Immunomonitoring Results of a Phase II/III Study of Malignant Ascites Patients Treated with the Trifunctional Antibody Catumaxomab (Anti-EpCAM × Anti-CD3)
    In: Cancer Research, Jg. 72, 2012, Nr. 1, S. 24 – 32
    DOI
  • Kuhlmann, Jan D.; Schwarzenbach, Heidi; Wimberger, Pauline; Poetsch, Micaela; Kimmig, Rainer; Kasimir-Bauer, Sabine
    LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survival
    In: BMC Cancer, Jg. 12, 2012, S. 325
    DOI, Online Volltext (Open Access)
  • Lordick, F.; Sehouli, J.; Vergote, I.; Rosenberg, P.; Schneeweiss, A.; Block, A.; Salat, C.; Scambia, G.; Berton-Rigaud, D.; Siena, S.; Santoro, A.; Cervantes-Ruiperez, A.; Guastalla, J. P.; Tournigand, C.; Colombo, N.; Dudnitchenko, A. S.; Bondar, V.; Westermann, A. M.; Wimberger, Pauline
    Maintenance of quality of life (QoL) and general health state in patients with malignant ascites during treatment with the trifunctional antibody catumaxomab : results from the phase III b CASIMAS trial
    In: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 62 – 63
  • Lordick, F.; Sehouli, J.; Vergote, I. B.; Rosenberg, P.; Schneeweiss, A.; Block, A.; Salat, C.; Scambia, G.; Berton-Rigaud, D.; Wimberger, Pauline
    Maintenance of quality of life in patients with malignant ascites during treatment with the trifunctional antibody catumaxomab : results from the phase III B casimas trial
    In: Annals of Oncology, Jg. 23, 2012, Nr. Suppl. 9, S. 514
  • Kuhlmann, Jan Dominik; Rasch, Jens; Wimberger, Pauline; Kasimir-Bauer, Sabine
    MicroRNA and the pathogenesis of ovarian cancer – a new horizon for molecular diagnostics and treatment?
    In: Clinical Chemistry and Laboratory Medicine, Jg. 50, 2012, Nr. 4, S. 601 – 615
    DOI
  • Soliman, Amr A.; Heubner, Martin; Kimmig, Rainer; Wimberger, Pauline
    Morbidity of inguinofemoral lymphadenectomy in vulval cancer
    In: The Scientific World Journal, 2012, S. 341253
    DOI
  • Du Bois, Andreas; Vergote, Ignace B.P.; Wimberger, Pauline; Ray-Coquard, Isabelle Laure; Harter, Philipp; Curtis, Lloyd; Mitrica, Ionel
    Open-label feasibility study of pazopanib, carboplatin, and paclitaxel in women with newly diagnosed, untreated, gynaecologic tumours : A phase I/II trial of the AGO study group
    In: British Journal of Cancer (BJC), Jg. 106, 2012, Nr. 4, S. 629 – 632
    DOI (Open Access)
  • Meier, Werner; Du Bois, Andreas; Rau, Jörn; Gropp-Meier, Martina; Baumann, Klaus; Huober, Jens; Wollschlaeger, Kerstin; Kreienberg, Rolf; Canzler, Ulrich; Schmalfeldt, Barbara; Wimberger, Pauline; Richter, Barbara; Schröder, Willibald; Belau, Antje; Stähle, Anne; Burges, Alexander; Sehouli, Jalid
    Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB-IV
    In: Gynecologic Oncology, Jg. 126, 2012, Nr. 2, S. 236 – 240
    DOI
  • Kasimir-Bauer, Sabine; Wimberger, Pauline; Kimmig, Rainer
    Schlafende Tumorzellen : Widerstandskämpfer der gynäkologischen Tumorerkrankungen
    In: Unikate: Berichte aus Forschung und Lehre, 2012, Nr. 42: Translationale Krebsforschung: Auf dem Weg zu neuen Therapien, S. 80 – 89
    DOI, Online Volltext (Open Access)
  • Hilpert, Felix; Wimberger, Pauline; Du Bois, Andreas; Pfisterer, Jacobus; Harter, Philipp
    Treatment of elderly ovarian cancer patients in the context of controlled clinical trials : A joint analysis of the AGO Germany experience
    In: Onkologie, Jg. 35, 2012, Nr. 3, S. 76 – 81
    DOI
  • Heubner, Martin; Errico, Dino; Kasimir-Bauer, Sabine; Herlyn, Dorothee; Kimmig, Rainer; Wimberger, Pauline
    EpCAM-autoantibody levels in the course of disease of ovarian cancer patients
    In: Medical Oncology, Jg. 28, 2011, Nr. 2, S. 626 – 630
    DOI
  • Wimberger, Pauline; Roth, Carina; Pantel, Klaus; Kasimir-Bauer, Sabine; Kimmig, Rainer; Schwarzenbach, Heidi
    Impact of platinum-based chemotherapy on circulating nucleic acid levels, protease activities in blood and disseminated tumor cells in bone marrow of ovarian cancer patients
    In: International Journal of Cancer, Jg. 128, 2011, Nr. 11, S. 2572 – 2580
    DOI (Open Access)
  • Baumann, Klaus; Pfisterer, Jacobus; Wimberger, Pauline; Burchardi, Nicole; Kurzeder, Christian; Du Bois, Andreas; Loibl, Sibylle; Sehouli, Jalid; Huober, Jens; Schmalfeldt, Barbara; Vergote, Ignace; Lück, Hans Joachim; Wagner, Uwe
    Intraperitoneal treatment with the trifunctional bispecific antibody Catumaxomab in patients with platinum-resistant epithelial ovarian cancer : A phase IIa study of the AGO Study Group
    In: Gynecologic Oncology, Jg. 123, 2011, Nr. 1, S. 27 – 32
    DOI
  • Kuhlmann, Jan Dominik; Schwarzenbach, Heidi; Otterbach, Friedrich; Heubner, Martin; Wimberger, Pauline; Worm, Karl-Heinz; Kimmig, Rainer; Kasimir-Bauer, Sabine
    Loss of heterozygosity proximal to the M6P/IGF2R locus is predictive for the presence of disseminated tumor cells in the bone marrow of ovarian cancer patients before and after chemotherapy
    In: Genes, Chromosomes and Cancer, Jg. 50, 2011, Nr. 8, S. 598 – 605
    DOI
  • Aktas, Bahriye; Kasimir-Bauer, Sabine; Heubner, Martin; Kimmig, Rainer; Wimberger, Pauline
    Molecular Profiling and Prognostic Relevance of Circulating Tumor Cells in the Blood of Ovarian Cancer Patients at Primary Diagnosis and After Platinum-Based Chemotherapy
    In: International Journal of Gynecological Cancer, Jg. 21, 2011, Nr. 5, S. 822 – 830
    DOI
  • Harter, P.; Canzler, U.; Lueck, H.; Reuss, A.; Meier, W.; Fehm, T. N.; Staehle, A.; Burges, A.; Kurzeder, C.; Sehouli, J.; Baumann, K. H.; Hanker, L. C.; Wimberger, Pauline; Schroeder, Willibald; Gropp, M.; Mahner, S.; Du Bois, A.
    Pegylated liposomal doxorubicin and carboplatin in malignant mixed epithelial mesenchymal and mesenchymal gynecologic tumors: A phase II trial of the AGO study group
    In: Journal of Clinical Oncology (JCO), Jg. 29, 2011, Nr. 15_suppl, S. 5093
    DOI
  • Schulze, E.; Parsons, S. L.; Heiss, M. M.; Wimberger, Pauline; Hennig, M.
    Prolonged ascites symptom-free time in patients with malignant ascites after treatment with catumaxomab
    In: Onkologie, Jg. 34, 2011, Nr. Suppl. 6, S. 167 – 168
  • Erim, Yesim; Beckmann, Mingo B.; Hoffmann, Oliver; Senf, Wolfgang; Kimmig, Rainer; Wimberger, Pauline
    Prädiktoren psychischer Belastungen bei Brustkrebspatientinnen : Worauf sollten Ärzte und Pflegekräfte in der onkologischen Praxis achten?
    In: Geburtshilfe und Frauenheilkunde, Jg. 71, 2011, Nr. 4, S. 285 – 291
    DOI
  • Heubner, Martin; Wimberger, Pauline; Dahlmann, Burkhardt; Kasimir-Bauer, Sabine; Kimmig, Rainer; Peters, Jürgen; Wohlschläger, Jeremias; Sixt, Stephan Urs
    The prognostic impact of circulating proteasome concentrations in patients with epithelial ovarian cancer
    In: Gynecologic Oncology, Jg. 120, 2011, Nr. 2, S. 233 – 238
    DOI
  • Battke, Christina; Ruiss, Romana; Welsch, Ulrich; Wimberger, Pauline; Lang, Stephan; Jochum, Simon; Zeidler, Reinhard
    Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCC.
    In: Cancer Immunology, Immunotherapy, Jg. 60, 2011, Nr. 5, S. 639 – 648
    DOI
  • Sehouli, Jaild; Taskova, V.; Hristamian, A.; Emons, Günther; Hanker, Lars C.; Gorchev, G.; Gründker, Carsten; Beckmann, Mathias W.; Stähle, Anne; Wimberger, Pauline
    378 Phase II study of AEZS-108 (AN-152), a targeted cytotoxic LHRH analog, in patients with LHRH receptor positive endometrial cancer. Protocol AGO-GYN 5, AGO Study Group, Germany
    In: European Journal of Cancer / EJC Supplements, Jg. 8, 2010, Nr. 7, S. 120
    DOI (Open Access)
  • du Bois, Andreas; Huober, Jens B.; Stopfer, Peter; Pfisterer, Jacobus; Wimberger, Pauline; Loibl, Sibylle; Reichardt, Volker L.; Harter, Philipp
    A phase I open-label dose-escalation study of oral BIBF 1120 combined with standard paclitaxel and carboplatin in patients with advanced gynecological malignancies
    In: Annals of Oncology, Jg. 21, 2010, Nr. 2, S. 370 – 375
    DOI (Open Access)
  • Harter, P.; Rau, Jeffrey E.; Wimberger, Pauline; Sehouli, Jalid; Hilpert, F.; Kurzeder, Christian; Elser, Gabriele; Klevesath, Manfred B.; du Bois, A.
    Addition of vandetanib to pegliposomal doxorubicin (PLD) in patients with recurrent ovarian cancer. A phase I randomised phase II trial of the AGO-OVAR. Results of the first safety analysis
    In: Onkologie, Jg. 33 Suppl. 2, 2010, S. 112 – 112
  • Mahner, Sven; du Bois, Andreas; Sehouli, Jalid; Reuss, Alexander; Baumann, Klaus; Hanker, Lars C.; Wimberger, Pauline; Schröder, Winnie; Gropp, Martina; Harter, Phillip
    Combination therapy with pegliposomal doxorubicin and carboplatin in malignant mixed epithelial mesenchymal gynecologic tumors. A prospective multicenter phase-II trial of the AGO Study Group
    In: Onkologie, Jg. 33 Suppl. 2, 2010, S. 107 – 108
  • Jäger, M.; Schoberth, Alexandra; Hennig, Michael; Burges, A.; Heiss, M.; Wimberger, Pauline; Schmalfeldt, B.; Lindhofer, Horst
    Immunomonitoring results of a pivotal phase II/III study with the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) in patients with malignant ascites
    In: Onkologie, Jg. 33 Suppl. 2, 2010, S. 158 – 158
  • Heubner, Martin; Kasimir-Bauer, Sabine; Kimmig, Rainer; Wimberger, Pauline
    Impact of disseminated tumor cells in bone marrow on outcome of patients with primary ovarian cancer
    In: Journal of Clinical Oncology (JCO), Jg. 28, 2010, Nr. Suppl. 15, S. e15545
    DOI
  • Wimberger, Pauline; Wehling, Michael; Lehmann, Nils; Kimmig, Rainer; Schmalfeldt, Barbara; Burges, Alexander; Harter, Philipp; Pfisterer, Jacobus; Du Bois, Andreas
    Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease
    In: Annals of Surgical Oncology, Jg. 17, 2010, Nr. 6, S. 1642 – 1648
    DOI
  • Ruf, Peter; Kluge, Michael; Jäger, Michael; Burges, Alexander; Volovat, Constantin; Heiss, Markus Maria; Hess, Jürgen; Wimberger, Pauline; Brandt, Birgit; Lindhofer, Horst
    Pharmacokinetics, immunogenicity and bioactivity of the therapeutic antibody catumaxomab intraperitoneally administered to cancer patients
    In: British Journal of Clinical Pharmacology (BJCP), Jg. 69, 2010, Nr. 6, S. 617 – 625
    DOI
  • du Bois, Andreas; Herrstedt, Jorn; Hardy-Bessard, Anne-Claire; Müller, Hans-Helge; Harter, Philipp; Kristensen, Gunnar; Joly, Florence; Huober, Jens; Avall-Lundqvist, Elisabeth; Weber, Beatrice; Kurzeder, Christian; Jelic, Svetislav; Pujade-Lauraine, Eric; Burges, Alexander; Pfisterer, Jacobus; Gropp, Martina; Stähle, Anne; Wimberger, Pauline; Jackisch, Christian; Sehouli, Jalid
    Phase III trial of carboplatin plus paclitaxel with or without gemcitabine in first-line treatment of epithelial ovarian cancer
    In: Journal of Clinical Oncology (JCO), Jg. 28, 2010, Nr. 27, S. 4162 – 4169
    DOI
  • Sehouli, Jalid; Pietzner, Klaus; Harter, Philipp; Münstedt, Karsten; Mahner, Sven; Hasenburg, Annette; Camara, Oumar; Wimberger, Pauline; Böhmer, Dirk; Buehling, K.J.; Richter, Rolf; El Khalfaoui, Khalid; Oskay-Ozcelik, Guelten
    Prognostic role of platinum sensitivity in patients with brain metastases from ovarian cancer : Results of a German multicenter study
    In: Annals of Oncology, Jg. 21, 2010, Nr. 11, S. 2201 – 2205
    DOI (Open Access)
  • Heubner, Martin; Wimberger, Pauline; Riemann, Kathrin; Kasimir-Bauer, Sabine; Otterbach, Friedrich; Kimmig, Rainer; Siffert, Winfried
    The CYP1A1 Ile462Val polymorphism and platinum resistance of epithelial ovarian neoplasms
    In: Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Jg. 18, 2010, Nr. 7, S. 343 – 347
    DOI
  • Heiss, Markus M.; Murawa, Pawel; Koralewski, Piotr; Kutarska, Elzbieta; Kolesnik, Olena O.; Ivanchenko, Vladimir V.; Dudnichenko, Alexander S.; Aleknaviciene, Birute; Razbadauskas, Arturas; Gore, Martin; Ganea-Motan, Elena; Ciuleanu, Tudor; Wimberger, Pauline; Schmittel, Alexander; Schmalfeldt, Barbara; Burges, Alexander; Bokemeyer, Carsten; Lindhofer, Horst; Lahr, Angelika; Parsons, Simon L.
    The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer : Results of a prospective randomized phase II/III trial
    In: International Journal of Cancer, Jg. 127, 2010, Nr. 9, S. 2209 – 2221
    DOI (Open Access)
  • Heubner, Martin; Wimberger, Pauline; Otterbach, Friedrich; Kasimir-Bauer, Sabine; Siffert, Winfried; Kimmig, Rainer; Nückel, Holger
    Association of the AA genotype of the BCL2 (-938C>A) promoter polymorphism with better survival in ovarian cancer
    In: The International Journal of Biological Markers (IJBM), Jg. 24, 2009, Nr. 4, S. 223 – 229
    DOI
  • Heubner, Martin; Wimberger, Pauline; Kasimir-Bauer, Sabine; Otterbach, Friedrich; Kimmig, Rainer; Siffert, Winfried
    The AA genotype of a L1C G842A polymorphism is associated with an increased risk for ovarian cancer.
    In: Anticancer Research, Jg. 29, 2009, Nr. 8, S. 3449 – 3452
  • Heubner, Martin; Riemann, Kathrin; Otterbach, Friedrich; Kimmig, Rainer; Kasimir-Bauer, Sabine; Siffert, Winfried; Wimberger, Pauline
    The haplotype of two FSHR polymorphisms in ovarian cancer : A potential role of ethnology in risk modification
    In: Gynecologic Oncology, Jg. 112, 2009, Nr. 3, S. 486 – 489
    DOI
  • Wimberger, Pauline; Heubner, Martin; Otterbach, Friedrich; Fehm, Tanja; Kimmig, Rainer; Kasimir-Bauer, Sabine
    Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancer
    In: Gynecologic Oncology, Jg. 107, 2007, Nr. 2, S. 331 – 338
    DOI

    • Aufsätze

  • du Bois, Andreas; Ewald-Riegler, Nina; de Gregorio, Nikolaus; Reuss, Alexander; Mahner, Sven; Fotopoulou, Christina; Kommoss, Friedrich; Schmalfeldt, Barbara; Hilpert, Felix; Fehm, Tanja; Burges, Alexander; Meier, Werner; Hillemanns, Peter; Hanker, Lars; Hasenburg, Annette; Strauss, Hans-Georg; Hellriegel, Martin; Wimberger, Pauline; Keyver-Paik, Mignon-Denise; Baumann, Klaus; Canzler, Ulrich; Wollschlaeger, Kerstin; Forner, Dirk; Pfisterer, Jacobus; Schröder, Willibald; Münstedt, Karsten; Richter, Barbara; Kommoss, Stefan; Hauptmann, Steffen
    Corrigendum to “Borderline tumours of the ovary: A cohort study of the Arbeitsgemeinschaft Gynäkologische Onkologie AGO Study Group”
    In: European Journal of Cancer (EJC). Amsterdam: Elsevier, Jg. 65, 2016, S. 192 – 193
    DOI

    • Abstracts

  • Bauerschlag, D; Marmé, F; Pietzner, K; Reuss, A; Heitz, F; El-Balat, A; Wimberger, Pauline; de Gregorio, N; Burges, A; Hasenburg, A; Fehm, T; Runnebaum, I B; Schmalfeldt, B; Hanker, L; Denschlag, D; Kommoss, S; Mach, P; Martina Gropp-Meier, M; Hilpert, F; Harter, P
    Atezolizumab versus Placebo in Kombination mit Bevacizumab und nicht-platinhaltiger Chemotherapie bei rezidivierendem Ovarialkarzinom : endgültige Gesamt- und progressionsfreie Überlebensergebnisse aus der AGO-OVAR 2.29/ENGOT-ov34-Studie
    In: Geburtshilfe und Frauenheilkunde. Stuttgart: Thieme, Jg. 85, 2025, Nr. 06, S. e11 – e12
    DOI
  • Czogalla, B.; Trillsch, F.; Heitz, F.; Mahner, S.; Loidl, V.; Aminossadati, B.; Malander, S.; de Gregorio, N.; Selle, F.; Wimberger, Pauline; Mirza, M.R.; Sehouli, J.; Lortholary, A.; Baumann, K.H.; Hilpert, F.; Canzler, U.; Hanker, L.C.; Pfisterer, J.; Harter, P.; du Bois, A.
    Anti-angiogenic therapy in first-line treatment of low-grade serous ovarian cancer : Exploratory meta-analysis of the prospective AGO-OVAR 11/12/16 studies
    ESMO Congress 2024, 13-17 September 2024, Barcelona, Spain,
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 35, 2024, Nr. Suppl. 2, S. S576 – S577
    DOI
  • Denschlag, D.; Heitz, F.; Fangmann, L.C.; Kerkmann, M.; Klecker, P.H.; Woelber, L.; Mach, P.; Fink, A.; Bokhua, D.; de Gregorio, N.; Hemptenmacher, F.; Friebe, V.; Wimberger, Pauline; Jaeger, A.; Mittelstadt, S.; Kalder, M.; Schröder, W.; Bronger, H.; Harter, P.; Czogalla, B.
    Treatment of patients with metastatic or relapsed cervical cancer : Results from a quality assurance program of the AGO Study Group
    ESMO Congress 2024, 13-17 September 2024, Barcelona, Spain,
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 35, 2024, Nr. Suppl. 2, S. S553 – S554
    DOI
  • Harter, Philipp; Ataseven, Beyhan; Burges, Alexander; Reuss, Alexander; Kommoss, Stefan; Sehouli, Jalid; Lampe, Bjoern; Schmalfeldt, Barbara; Wimberger, Pauline; Witteler, Ralf; Buderath, Paul; Herwig, Uwe; Bronger, Holger; Emons, Guenter; Klar, Maximillian; Hasenburg, Annette; de Gregorio, Nikolaus; Hilpert, Felix; Du Bois, Andreas; Mahner, Sven
    Diagnosis of first relapse and its impact on quality of life in patients with advanced ovarian cancer (AGO-OVAR 19/II)
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 40, 2022, Nr. 16_Suppl., S. e17609
    DOI (Open Access)
  • Kuhlmann, J. D.; Gerber, M. J.; Pfisterer, J.; Kimmig, Rainer; Heitz, F.; Sehouli, J.; Hilpert, F.; Wimberger, Pauline; et al.
    Immunohistochemical expression of the anti-angiogenic VEGF-A splice variant VEGF-A165b as predictive biomarker for bevacizumab treatment in advanced ovarian cancer patients
    15. Jahrestagung der Mitteldeutschen Gesellschaft für Frauenheilkunde und Geburtshilfe e.V. (MGFG), 17.-18.06.2022, Halle an der Saale,
    In: Geburtshilfe und Frauenheilkunde. Stuttgart: Thieme, Jg. 82, 2022, Nr. 6: Kongressabstracts zur 15. Jahrestagung der Mitteldeutschen Gesellschaft für Frauenheilkunde und Geburtshilfe e.V. (MGFG), S. E30 – E31
    DOI, Online Volltext
  • Sehouli, Jalid; Oskay-Özcelik, Gülten; Zocholl, Dario; Klemt, Anna-Sophia; Bangemann, Nikola; Albrecht, Oliver; Strittmatter, Hans-Joachim; Wimberger, Pauline; Kaczerowsky, Anna; Lorenz, Ralf; Ruhwedel, Wencke; Fehm, Tanja N.; Zahn, Andreas; Tome, Oliver; Markert, Miriam; Hager, Dietrich; Zorr, Andreas; Keller, Maren; Rittmeister, Hannah; Grabowski, Jacek P.
    Prospective, multicenter study on non-pharmacological, patient related predictive factors of chemotherapy induced nausea and vomiting (CINV) : A NOGGO-EMRISK trial
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 40, 2022, Nr. 16_Suppl., S. e24107
    DOI (Open Access)
  • Salmon, Carolin; Levermann, Janina; Buderath, Paul; Kuhlmann, Jan Dominik; Wimberger, Pauline; Kimmig, Rainer; Kasimir-Bauer, Sabine
    Image-based identification of single circulating tumor cells in ovarian cancer patients for genomic analysis
    AACR Annual Meeting 2021, April 10-15, 2021 and May 17-21, 2021, Philadelphia, PA, USA,
    In: Cancer Research. Philadelphia: American Association for Cancer Research (AACR), Jg. 81, 2021, Nr. Suppl. 13, 594
    DOI
  • Wimberger, Pauline; Sehouli, J.; Schmalfeldt, B; Rau, J.; Thiel, F; Hanker, L; Marmé, F; El-Balat, A; De Gregorio, N; Baumann, K; Mahner, S; Park-Simon, TW; Meier, W; Kommoss, S; Bauerschlag, D; Lück, Hans-Joachim; Kimmig, Rainer; Burges, A; Schröder, W; Jackisch, C; Gropp-Meier, M; Harter, Philipp; Pfisterer, J
    Carboplatin/PLD/Bevacizumab als neue Standardtherapieoption beim Ovarialkarzinomspätrezidiv – aktuelle Ergebnisse der AGO OVAR 2.21 Studie
    In: Geburtshilfe und Frauenheilkunde. Stuttgart: Thieme, Jg. 80, 2020, Nr. 10, S. e91
    DOI
  • Hasenburg, Annette; Plett, H.; Krämer, B.; Braicu, Elena Ioana; Czogalla, Bastian; Bossart, Michaela; Singer, S.; Mayr, David; Staebler, Axel; du Bois, Andreas; Kommoss, Stefan; Link, Theresa; Burges, Alexander; Heitz, Florian; Keul, J.; Trillsch, F.; Harter, P.; Wimberger, Pauline; Buderath, Paul; Klar, M.
    The effect of surgical techniques on sexuality and global quality of life (Qol) in women with ovarian germ cell (OGCT) and sex cord stromal tumours (SCST) : An analysis of the AGO-CORSETT database
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 31, 2020, Nr. Suppl. 4, S. S643 – S644
    DOI (Open Access)
  • Wimberger, Pauline; Bachmann, Hagen Sjard; Kuhlmann, J. D.; Link, T.; Kroeber, E.; Thomssen, C.
    Association of Caspase 8 polymorphisms with TILs and disease-free survival in primary breast cancer patients
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 36, 2018, Nr. Suppl. 15, S. e24258
    DOI (Open Access)
  • Wimberger, Pauline; Chebouti, I.; Kuhlmann, J. D.; Buderath, P.; Weber, Stefanie; Bokeloh, Y.; Hauch, S.; Kimmig, Rainer; Kasimir-Bauer, Sabine
    ERCC1-Expressinf Circulating Tumor Cells as a Potential Diagnostic Tool for Monitoring Platinum-Based Chemotherapy and for Predicting Outcome of Ovarian Cancer
    In: International Journal of Gynecological Cancer. London: BMJ Publishing Group, Jg. 27, 2017, Nr. Suppl. 4, S. ESGO7 – 0140
    DOI
  • Blassl, C.; Chebouti, I.; Wimberger, Pauline; Fehm, T.; Kimmig, Rainer; Neubauer, H.; Kasimir-Bauer, Sabine
    Analysis of disseminated tumor cells before and after platinum-based chemotherapy in primary ovarian cancer : Do stem cell like cells predict prognosis?
    Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ ; 32. Deutscher Krebskongress ; 24.-27. Februar 2016, Berlin,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 39, 2016, Nr. Suppl. 1, S. 22
    DOI
  • Kuhlmann, J. D.; Baraniskin, A.; Hahn, S.; Mosel, Frank; Bredemeier, M.; Wimberger, Pauline; Kimmig, Rainer; Kasimir-Bauer, Sabine
    Circulating U2 small nuclear RNA fragments as a novel diagnostic tool for patients with epithelial ovarian cancer
    Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ ; 32. Deutscher Krebskongress ; 24.-27. Februar 2016, Berlin,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 39, 2016, Nr. Suppl. 1, S. 95 – 96
    DOI
  • Schramm, A.; Friedl, T.; Rack, B.; Trapp, E.; Fasching, P. A.; Taran, F. A.; Hartkopf, A.; Schneeweiss, A.; Muller, V.; Aktas, Bahriye; Pantel, K.; Meier-Stiegen, F.; Wimberger, Pauline; Kümmel, Sherko; Gebauer, G.; Muller, L.; Janni, W.; Fehm, T.
    The DETECT Study Concept - Metastatic breast cancer and circulating tumor cells
    In: Oncology Research and Treatment. Basel: Karger, Jg. 39, 2016, Nr. Suppl. 1: Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ 32. Deutscher Krebskongress (DKK), Berlin, Februar 2016: Abstracts, S. 46 – 47
  • Schramm, A.; Fried, T. W. P.; Huober, J.; Jager, B.; Rack, B.; Trapp, E.; Fasching, P. A.; Taran, F. A.; Hartkopf, A.; Schneeweiss, A.; Muller, V.; Aktas, Bahriye; Pante, K.; Meier-Stiegen, F.; Wimberger, Pauline; Kümmel, Sherko; Gebauer, G.; Muller, L.; Janni, W.; Fehm, T.
    The DETECT study program - Personalized treatment in metastatic breast cancer based on circulating tumor cells
    Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium, December 8-12, 2015, San Antonio, TX, USA,
    In: Cancer Research. Philadelphia: American Association for Cancer Research (AACR), Jg. 76, 2016, Nr. 4, Supplement, OT1-02-02
    DOI
  • Bachmann, Hagen Sjard; Meier, W.; du Bois, A.; Kimmig, Rainer; Kuhlmann, J. D.; Siffert, Winfried; Sehouli, J.; Wollschlaeger, K.; Huober, J.; Hillemanns, P.; Burges, A.; Schmalfeldt, B.; Aminossadati, B.; Wimberger, Pauline
    The FNTB-609G > C polymorphism as a possible predictive factor for efficacy of lonafarnib-treatment? : Exploratory analysis of a randomized phase II clinical trial in stage IIb-IV ovarian cancer, treated with first-line platinum-based chemotherapy with or without lonafarnib
    Deutsche Gesellschaft für Experimentelle und Klinische Pharmakologie und Toxikologie e.V., 81th Annual Meeting, March 10 - 12, 2015, Kiel, Germany,
    In: Naunyn-Schmiedeberg's Archives of Pharmacology. Berlin: Springer, Jg. 388, 2015, Nr. Suppl. 1, S. 52
    DOI
  • Hillemanns, P.; Wolber, L.; Juckstock, J.; Neuser, P.; Hilpert, F.; Harter, P.; De Gregorio, N.; Hasenburg, A.; Sehouli, J.; Habermann, A.; Fuerst, S. T.; Strauss, H. G.; Baumann, K.; Thiel, F.; Mustea, A.; Meier, W.; Du Bois, A.; Wimberger, Pauline; Hanker, L.; Schmalfeldt, B.; Canzler, U.; Fehm, T.; Luyten, A.; Hellriegel, M.; Kosse, J.; Heiss, C.; Hantschmann, P.; Mallmann, P.; Tanner, B.; Pfisterer, J.; Richter, B.; Petersen, C.; Mahner, S.
    AGO Vulva CaRE-1 multicenter study - adjuvant radio(chemo)therapy in vulvar cancer
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 1, S. 70
    DOI
  • Gropp-Meier, M.; Schmalfeld, B.; Belau, A.; Rau, J.; Richter, B.; Emons, G.; Hillemanns, P.; Luck, H. J.; Burges, A.; Fehm, T.; Harter, P.; Wimberger, Pauline; Baumann, K.; Kurzeder, C.; Canzler, U.; Meier, W.; Hanker, L. C.; Mahner, S.; Kosse, J.; Sehouli, J.; Sutterlin, M.; Zorr, A.; du Bois, A.
    Influence of the postoperative residual tumor on the outcome of therapy with pazopanib in ovarian cancer (OC) : A subgroup analysis of an international intergroup trial (AGO-OVAR16)
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 1, S. 69
    DOI
  • Wolber, L.; Jueckstock, J.; Hilpert, F.; Neuser, P.; Harter, P.; De Gregorio, N.; Iborra, S.; Sehouli, J.; Habermann, A.; Hillemanns, P.; Furst, S.; Strauss, H. G.; Baumann, K. H.; Thiel, F.; Mustea, A.; Meier, W.; Du Bois, A.; Wimberger, Pauline; Hanker, L. C.; Schmalfeldt, B.; Canzler, U.; Fehm, T.; Luyten, A.; Hellriegel, M.; Kosse, J.; Heiss, C.; Hantschmann, P.; Mallmann, P.; Tanner, B.; Pfisterer, J.; Richter, B.; Griebel, L. F.; Mahner, S.
    Outcome parameters in node-negative vulvar cancer - subset analysis of the AGO CaRE-1 study
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 1, S. 72 – 73
    DOI
  • Trillsch, F.; Mahner, S.; Rutzel, J. D.; Vettorazzi, E.; Reuss, A.; Hillemanns, P.; Hanker, L.; Hasenburg, A.; Strauss, H. G.; Hellriegel, M.; Wimberger, Pauline; Klaus, B.; Keyver-Paik, M. D.; Canzler, U.; Wollschlaeger, K.; Forner, D.; Pfisterer, J.; Schroder, W.; Munstedt, K.; Richter, B.; Fotopoulou, C.; Schmalfeldt, B.; Burges, A.; Fehm, T.; Meier, W.; Ewald-Riegler, N.; De Gregorio, N.; Hilpert, F.; Du Bois, A.
    Prognostic impact of the time interval between primary and re-staging surgery in patients with borderline ovarian tumours (BOT) : An analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Study Group
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 1, S. 71 – 71
    DOI
  • Wölber, Linn Lena; Sehouli, Jalid; Habermann, Anika; Hillemanns, Peter; Neuser, Petra; Fürst, Sophie; Strauss, Hans-Georg; Baumann, Klaus H.; Thiel, Falk Clemens; Mustea, Alexander; Meier, Werner; Harter, Philipp; Wimberger, Pauline; Hanker, Lars Christian; Schmalfeldt, Barbara; Canzler, Ulrich; Fehm, Tanja N.; Luyten, Alexander; Hellriegel, Martin; Mahner, Sven
    Resection margin and locoregional control in vulvar cancer : A subset analysis of the AGO CARE-1 multicenter study
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 32, 2014, Nr. 15, Suppl., S. 5608
    DOI
  • Kuhlmann, J. D.; Wimberger, Pauline; Bankfalvi, Agnes; Keller, Thomas; Scholer, S.; Aktas, B.; Buderath, P.; Hauch, S.; Kimmig, Rainer; Kasimir-Bauer, Sabine
    The detection of excision repair cross-complementing rodent repair deficiency, complementation group 1-positive circulating tumor cells in the blood of ovarian cancer patients as a predictive biomarker for platinum-resistance
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 1, S. 3
    DOI
  • Salek, M.S.; Schmidt-Rimpler, C.; Wimberger, Pauline; Gilet, H.; Parsons, S.L.
    Converting EORTC QOl-C30 Scores to Utility Values : Is it Plausible?
    In: Value in Health. New York; Malden, Mass.: Elsevier, Jg. 15, 2012, Nr. 7, S. A478
    DOI (Open Access)
  • Kuhlmann, Jan Dominik; Hahn, Stephan; Baraniskin, Alexander; Wimberger, Pauline; Kasimir-Bauer, Sabine
    MicroRNA-1246 as a novel candidate for a blood-based biomarker in ovarian cancer patients
    In: Cancer Research. Philadelphia: American Association for Cancer Research (AACR), Jg. 72, 2012, Nr. 8, Suppl., S. 4132
    DOI
  • Gilet, H.; Parsons, S.L.; Deger, M.; Salek, M.S.; Wimberger, Pauline
    PCN117 Quality of Life in Patients With Malignant Ascites After Treatment With Catumaxomab : A Multicenter Phase II/III Study Comparing Paracentesis Plus Catumaxomab With Paracentesis Alone
    In: Value in Health. New York; Malden, Mass.: Elsevier, Jg. 15, 2012, Nr. 7, S. A430 – A431
    DOI (Open Access)
  • Schmalfeldt, B.; Seck, K.; Gonschior, A. K.; Gilet, H.; Heiss, M.; Hennig, M.; Moehler, M.; Schulze, E.; Wimberger, Pauline; Parsons, S. L.
    Quality of life in patients with malignant ascites and after treatment with catumaxomab : results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone
    In: Geburtshilfe und Frauenheilkunde. Stuttgart: Thieme, Jg. 72, 2012, Nr. 4, S. A12
    DOI
  • Wimberger, Pauline; Kasimir-Bauer, Sabine; Aktas, B.; Kimmig, Rainer; Heubner, Martin L.
    Are mesothelin and L1CAM useful biomarkers in primary ovarian cancer patients?
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 29, 2011, Nr. 15, Suppl., S. e15559
    DOI
  • Kuhlmann, Jan D.; Schwarzenbach, Heidi; Otterbach, Friedrich; Heubner, Martin; Wimberger, Pauline; Worm, Karl H.; Kimmig, Rainer; Kasimir-Bauer, Sabine
    Primary tumor loss of heterozygosity proximal to M6P/IGF2R locus is predictive for the presence and persistence of disseminated tumor cells in the bone marrow of ovarian cancer patients
    In: Cancer Research. Philadelphia: American Association for Cancer Research (AACR), Jg. 71, 2011, Nr. 8, Suppl., S. 2217
    DOI
  • Schulze, E.; Schmalfeldt, B.; Gonschior, A.; Hennig, M.; Parsons, S.L.; Heiss, M.M.; Gilet, H.; Wimberger, Pauline; Moehler, M.
    Quality of Life in Patients With Malignant Ascites and Ascites Symptoms After Treatment With Catumaxomab : Results From a Multicenter Phase ll/lll Study Comparing Paracentesis Plus Catumaxomab With Paracentesis Alone
    In: European Journal of Cancer (EJC). Amsterdam: Elsevier, Jg. 47, 2011, Nr. Suppl. 1, S. S223
    DOI

    • Beiträge in Sammelwerken und Tagungsbänden

  • Untch, M.; Ditsch, N.; Wimberger, Pauline; Kimmig, Rainer; Möbus, V.
    Basic principles of dose intensity and high-dose chemotherapy
    In: Chemotherapy for Gynecological Neoplasms: Current Therapy and Novel Approaches / Angioli, Roberto (Hrsg.). New York [u.a.]: Dekker, 2004, S. 57 – 65

    • Poster / Posterbeiträge

  • Fehm, Tanja; Mueller, Volkmar; Banys-Paluchowski, Maggie; Fasching, Peter A.; Friedl, Thomas W. P.; Hartkopf, Andreas; Huober, Jens; Loehberg, Christian; Rack, Brigitte; Riethdorf, Sabine; Schneeweiss, Andreas; Wallwiener, Diethelm; Meier-Stiegen, Franziska; Hoffmann, Oliver; Müller, Lothar; Wimberger, Pauline; Ruckhaeberle, Eugen; Blohmer, Jens; Janni, Wolfgang
    Efficacy of the tyrosine kinase inhibitor lapatinib in the treatment of patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells : results from the randomized phase III DETECT III trial
    San Antonio Breast Cancer Virtual Symposium ; December 8-11, 2020; San Antonio, Texas,
    In: Cancer Research. Philadelphia: American Association for Cancer Research (AACR), Jg. 81, 2021, Nr. 4, Supplement, S. PD3 – 12
    DOI (Open Access)
  • Müller, Volkmar; Banys-Paluchowski, Maggie; Friedl, Thomas W. P.; Fasching, Peter A.; Schneeweiss, Andreas; Hartkopf, Andreas; Wallwiener, Diethelm; Rack, Brigitte; Meier-Stiegen, Franziska; Huober, Jens; Rübner, Matthias; Hoffmann, Oliver; Müller, Lothar; Janni, Wolfgang; Wimberger, Pauline; Jäger, Bernadette; Pantel, Klaus; Harbeck, Nadia; Fehm, Tanja
    Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program
    San Antonio Breast Cancer Virtual Symposium ; December 8-11, 2020; San Antonio, Texas,
    In: Cancer Research. Philadelphia: American Association for Cancer Research (AACR), Jg. 81, 2021, Nr. 4, Supplement, S. PS2 – 02
    DOI (Open Access)